financetom
Business
financetom
/
Business
/
Marsh McLennan's insurance business boosts quarterly profit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marsh McLennan's insurance business boosts quarterly profit
Oct 16, 2025 4:14 AM

Oct 16 (Reuters) - Insurance broker Marsh McLennan ( MMC )

reported a rise in third-quarter adjusted profit on

Thursday, helped by strong performance in its risk and insurance

services business.

Spending on insurance recovered in the reporting quarter

after a period of uncertainty tied to U.S. President Donald

Trump's shifting tariff policies.

Brokers generate revenue through commissions based on

premiums, tying their performance closely with the insurance

industry's numbers.

Revenue in Marsh McLennan's ( MMC ) risk and insurance services

business came in at $3.9 billion, up 13% from a year earlier.

New York-based Marsh McLennan ( MMC ) caters to clients in over 100

countries across four businesses - Marsh, Guy Carpenter,

Mercer and Oliver Wyman.

However, the company said earlier in the week that it will

change its brand to Marsh, effective January, while the four

businesses will move to the new brand from 2027 following a

transition period.

Shares of the company have lost about 4% so far in 2025.

Revenue in its consultancy arm increased 9% to $2.5 billion,

helping the company record an 11% rise in total revenue to $6.4

billion for the three months ended September 30.

Adjusted net income attributable to Marsh McLennan ( MMC ) came in

at $911 million, or $1.85 per share, for the third quarter,

compared with $825 million, or $1.66 per share, in the year-ago

period.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GSK expects softer 2026 sales growth as new CEO Miels prepares change in course
GSK expects softer 2026 sales growth as new CEO Miels prepares change in course
Mar 11, 2026
* GSK says vaccine and general medicines sales may decline in 2026 * Company maintains long-term targets * GSK shifting focus to pipeline expansion and commercial execution * Q4 and 2025 sales beat analyst expectations (Adds details, background, analyst consensus and shares) Feb 4 (Reuters) - In the first outlook presented by new CEO Luke Miels, ‌GSK on Wednesday said...
Novo Nordisk sees 'painful' US price cuts for Wegovy as investment in  the future
Novo Nordisk sees 'painful' US price cuts for Wegovy as investment in  the future
Mar 11, 2026
COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Wednesday that ‌the price reductions for ​its obesity drug Wegovy ‍in the U.S. ⁠are painful ⁠for the company's financial results ‌but he ​hopes that they will be an ⁠investment in ‍the ​future as many more people will be able ‍to get access to the medicines as a result....
Equinor Q4 Adjusted Earnings Rise, Revenue Falls
Equinor Q4 Adjusted Earnings Rise, Revenue Falls
Mar 11, 2026
03:22 AM EST, 02/04/2026 (MT Newswires) -- Equinor ( EQNR ) reported Q4 adjusted earnings Wednesday of $0.81 per diluted share, up from $0.63 a year earlier. Analysts polled by FactSet expected $0.61. Revenue for the quarter ended Dec. 31 was $25.35 billion, down from $27.65 billion a year earlier. Analysts surveyed by FactSet expected $22.06 billion. ...
Volvo Cars' sales volumes drop 7% in November-January period in challenging market 
Volvo Cars' sales volumes drop 7% in November-January period in challenging market 
Mar 11, 2026
COPENHAGEN, Feb 4 (Reuters) - Sweden-based Volvo Cars sold 177,830 cars in the November-January period, down 7% from the ‌same period a year earlier, it said ​on Wednesday. Volvo Cars, which is ‍majority-owned by China's Geely ⁠Holding, said ⁠in a statement sales volumes for ‌fully electric models ​rose 13% to account for 24% of all cars ⁠sold in ‍the period....
Copyright 2023-2026 - www.financetom.com All Rights Reserved